Impact of age-related cerebral white matter changes on the transition to disability -- the LADIS study: rationale,

Leonardo Pantoni1, Anna Maria Basile, Giovanni Pracucci

  • 1Department of Neurological and Psychiatric Sciences, University of Florence, Florence, Italy. pantoni@neuro.unifi.it

Neuroepidemiology
|October 2, 2004
PubMed

Insights

Age-related white matter changes (ARWMC) predict disability transition in older adults. This study tracked ARWMC progression to understand its role in elderly disability and inform prevention strategies.

Area of Science:

  • Neurology
  • Geriatrics
  • Radiology

Background:

  • Age-related white matter changes (ARWMC) are linked to cognitive, motor, mood, and urinary issues in the elderly.
  • The direct impact of ARWMC and its progression on the development of disability in older adults remains unclear.

Purpose of the Study:

  • To evaluate Age-related white matter changes (ARWMC) as an independent predictor of disability transition in non-disabled elderly individuals (65-84 years).
  • The LADIS (Leukoaraiosis and Disability in the Elderly) study aims to assess the role of ARWMC in the onset of disability.

Main Methods:

  • Enrolled 639 initially non-disabled elderly participants (mean age 74.13 years) across 11 European centers.
  • Assessed participants at baseline using comprehensive clinical, functional, cognitive, motor, and quality of life measures.
  • Categorized ARWMC severity (mild, moderate, severe) using the Fazekas scale; MRI scans performed at baseline and follow-up.

Main Results:

  • Primary outcome: transition to disability, defined as impairment in 2 or more Instrumental Activities of Daily Living (IADL) items.
  • Secondary outcomes included dementia, depression, vascular events, and death.
  • Longitudinal follow-up up to 3 years to analyze ARWMC progression and its relationship with disability.

Conclusions:

  • The LADIS study provides comprehensive data to examine functional and clinical features in relation to ARWMC severity and patterns.
  • Findings will elucidate the role of ARWMC and its progression as independent contributors to elderly disability.
  • Results may inform preventive strategies and standardize tools for early disability identification in the aging population.

Related Concept Videos

Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Cognitive Development During Adulthood01:30

Cognitive Development During Adulthood

Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...